// App-Quantinova.ai

: Impact of IKZF1 Deletions and IKZF1 Plus in Pediatric Acute Lymphoblastic Leukemia Outcome

Researchers

Presenter

  • Maria Sara Felice

Principal Investigators

  • Patricia Laura Rubio

  • Myriam Ruth Guitter

  • Jorge Gabriel Rossi

  • Jorge Alberto Digiorge

  • Maria Constanza Guardia

  • Maria Angelica Fernndez Barbieri

  • Gladys Gutierrez

  • Ezequiel Recondo

  • Maria Soledad Vides Herrera

  • Vanina Livio

  • Cristina Noemi Alonso

Medical Centers

  • Hematology-Oncology, Nacional de Pediatria Prof. Dr. Juan P Garrahan, buenos aires, Argentina

  • Immunology and Rheumatology, Hospital Nacional de Pediatria Prof. Dr. J. P. Garrahan, Buenos Aires, Argentina

  • Hospital Niño Jesús, Tucumán, Argentina

  • Hematology and Oncology, Hospital Materno Infantil San Isidro, Buenos Aires, Argentina

  • Hematology and Oncology, Hospital Pediatrico Juan Pablo II, Corrientes, Argentina

  • Hematology and Oncology, Hospital Nacional de Clinicas, Caba, ARG

  • Hematology and Oncology, Hospital de Niños Eva Peron, San Fernando del Valle de Catamarca, Argentina

  • Hematology and Oncology, Hospital Pediatrico Dr Avelino Castelán, Resistencia, Argentina

Locations

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Paired box 5

  • Cyclin Dependent Kinase Inhibitor 2A

  • Cyclin Dependent Kinase Inhibitor 2B

  • Retinoblastoma protein

  • ETV6-RUNX1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved